NAB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.001800E-01
Normal-vs-Stage2
2.799200E-01
Normal-vs-Stage3
9.555200E-01
Normal-vs-Stage4
4.368000E-02
Stage1-vs-Stage2
6.105000E-01
Stage1-vs-Stage3
3.703600E-01
Stage1-vs-Stage4
1.552380E-01
Stage2-vs-Stage3
2.336000E-01
Stage2-vs-Stage4
4.251000E-01
Stage3-vs-Stage4
7.388200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.160000E-01
Normal-vs-AfricanAmerican
3.460400E-01
Normal-vs-Asian
8.006000E-01
Caucasian-vs-AfricanAmerican
9.286400E-01
Caucasian-vs-Asian
1.312050E-01
AfricanAmerican-vs-Asian
3.044600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.108600E-01
Normal-vs-Female
3.454200E-01
Male-vs-Female
3.432000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.871000E-01
Normal-vs-Age(41-60Yrs)
1.914390E-01
Normal-vs-Age(61-80Yrs)
3.884800E-01
Normal-vs-Age(81-100Yrs)
4.149600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.450000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.702600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.757200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.605200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.605400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.177800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.280000E-01
Normal-vs-Daily Drinker
5.420200E-01
Normal-vs-Weekly Drinker
4.727200E-01
Normal-vs-Occasional Drinker
1.385440E-01
Normal-vs-Social Drinker
2.775200E-01
Non Drinker-vs-Daily Drinker
9.671400E-01
Non Drinker-vs-Weekly Drinker
6.340200E-01
Non Drinker-vs-Occasional Drinker
1.747420E-01
Non Drinker-vs-Social Drinker
5.760600E-01
Daily Drinker-vs-Weekly Drinker
6.695600E-01
Daily Drinker-vs-Occasional Drinker
2.999400E-01
Daily Drinker-vs-Social Drinker
6.857200E-01
Weekly Drinker-vs-Occasional Drinker
6.907000E-01
Weekly Drinker-vs-Social Drinker
9.227400E-01
Occasional Drinker-vs-Social Drinker
5.001800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.640400E-02
Normal-vs-Grade 2
8.782100E-03
Normal-vs-Grade 3
1.460100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.759760E-03
Grade 1-vs-Grade 3
2.979900E-04
Grade 1-vs-Grade 4
8.640400E-02
Grade 2-vs-Grade 3
7.896200E-02
Grade 2-vs-Grade 4
8.782100E-03
Grade 3-vs-Grade 4
1.460100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.846400E-01
Normal-vs-NonDiabetic
3.389200E-01
Diabetic-vs-NonDiabetic
5.542800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.366000E-01
Normal-vs-NoPancreatitis
3.750600E-01
Pancreatitis-vs-NoPancreatitis
9.446000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.913000E-01
Normal-vs-N1
2.810200E-01
N0-vs-N1
4.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.520230E-03
Normal-vs-TP53-NonMutant
6.157400E-01
TP53-Mutant-vs-TP53-NonMutant
8.24740000000546E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
